Basic Information
LncRNA/CircRNA Name | SNHG14 |
Synonyms | NA |
Region | GRCh38_15:24978583-25419462 |
Ensemble | ENSG00000224078 |
Refseq | NR_146177 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | Trastuzumab | |
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, ChIP |
Sample | breast cancer tissues, cell lines (SKBR-3, BT474) |
Expression Pattern | up-regulated |
Function Description | RT-qPCR assay showed that SNHG14 was up-regulated in breast cancer tissues and associated with trastuzumab response.Gain- and loss-of-function experiments revealed that overexpression of SNHG14 promotes cell proliferation, invasion and trastuzumab resistance, overexpression of SNHG14 suppressed the trastuzumab-induced cell apoptosis in BT474 parental cells whereas knockdown of SNHG14 enhanced the apoptosis caused by trastuzumab in SKBR-3/Tr cells. |
Pubmed ID | 30063126 |
Year | 2018 |
Title | Long Non-Coding RNA SNHG14 Induces Trastuzumab Resistance of Breast Cancer via Regulating PABPC1 Expression Through H3K27 Acetylation. |
External Links
Links for SNHG14 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |